Ketosis and Rebound COVID: Keto5 Files for Patent for Its Exogenous Ketone Salt Products as an Adjunct Supplement for Licensed COVID Treatment Paxlovid, Which May Help Reduce Rebound COVID Cases ...Middle East

Recent studies have shown higher levels of ketosis in the body may work with COVID therapies to boost the immune system, reduce virus replication, and improve patient outcomes BEVERLY HILLS, Calif., Aug. 24, 2022 /PRNewswire/ -- Keto5, (https://keto5.com/ ), a doctor-founded Beverly...

Hence then, the article about ketosis and rebound covid keto5 files for patent for its exogenous ketone salt products as an adjunct supplement for licensed covid treatment paxlovid which may help reduce rebound covid cases was published today ( Wednesday 24/08/2022 - 03:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ketosis and Rebound COVID: Keto5 Files for Patent for Its Exogenous Ketone Salt Products as an Adjunct Supplement for Licensed COVID Treatment Paxlovid, Which May Help Reduce Rebound COVID Cases )

Also on site :

• Robert Reed’s Daughter, Who Appeared on 'The Brady Bunch', Dies at 69
• Canada Dry Brings Back Popular Flavor That Once Flew off Shelves
• '90s Rocker Announces Update on First Solo Album 26 Years After Leaving Band